Table 3.
Number of dalys and ASDR for interstitial lung disease and pulmonary sarcoidosis in 1990 and 2021, and changes in number of dalys and ASDR from 1990 to 2021
| Item | 1990 | 2021 | 1990–2021 | ||||
|---|---|---|---|---|---|---|---|
| Number | ASDR per 100,000 | Number | ASDR per 100,000 | Percentage changes, % | AAPC, % | EAPC, % | |
| Global | 1501028.43(1221196.88-1850556.94) | 37.15(30.62–45.37) | 4042150.49(3489794.64-4516882.92) | 47.62(41.26–53.16) | 0.28(0.13-0.50) | 0.83 (0.74–0.92) | 0.95 (0.86-1.0) |
| Sex | |||||||
| Male | 853132.96(666666.89-1066356.17) | 46.48(36.62–57.59) | 2237269.37(1839499.94-2555199.73) | 57.79(47.50-65.77) | 0.24(0.09-0.44) | 0.71 (0.60–0.83) | 0.85 (0.76–0.9) |
| Female | 647895.47(500164.80-883303.45) | 29.79(23.23–40.19) | 1804881.12(1465706.81-2216375.57) | 39.49(31.95–48.62) | 0.33(0.14-0.70) | 0.91 (0.79–1.03) | 1.07 (0.96–1.1) |
| SDI* | |||||||
| Low | 126670.88(60835.33-188619.3) | 53.16(27.07–75.28) | 291854.54(178639.62-406439.75) | 56.02(34.43–78.83) | 0.05(−0.23-0.47) | 0.20 (0.00–0.40) | 0.31 (0.21–0.4) |
| Low-middle | 359489.06(213851.92-552928.69) | 57.35(34.67–86.88) | 949437.88(662365.39-1260418.62) | 66.55(46.34–88.36) | 0.16(−0.07-0.64) | 0.51 (0.17–0.84) | 0.64 (0.57–0.7) |
| Middle | 269855.74(212977.03-366218.84) | 25.08(19.94–33.57) | 812056.09(695675.28-984261.99) | 31.00(26.55–37.41) | 0.24(0.01-0.56) | 0.74 (0.50–0.98) | 0.83 (0.76–0.9) |
| High-middle | 237514.38(213560.48-266885.04) | 23.58(21.53–26.81) | 485511.72(430895.70-541669.29) | 25.48(22.63–28.47) | 0.07(−0.05-0.19) | 0.18 (−0.15–0.52) | 0.41 (0.32–0.5) |
| High | 506204.64(470841.19-546440.49) | 46.54(43.29–50.27) | 1500929.60(1354746.32-1614665.30) | 71.40(65.27–76.57) | 0.53(0.45-0.62) | 1.41 (1.14–1.68) | 1.54 (1.34–1.7) |
ASDR Age-standardized DALYs rate, AAPC Average Annual Percentage Change, SDI Sociodemographic Index, EAPC Estimated Annual Percentage Change. *P < 0.05